In previous Updates, we discussed the formation and growth of the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium), which was started by the Biomedical Advanced Research and ...

-BioMap’s AI drug discovery platform integrates foundational large language models and super-scale computing with cutting-edge biotechnology to discover novel targets and design biologics through a ...

Sanofi’s ambition to become “the first pharma company powered by artificial intelligence at scale” came one step closer today in a deal with California’s BioMap worth over $1 billion in biobucks.

Hong Kong, SAR--(Newsfile Corp. - June 24, 2024) - Hong Kong Science Park Corporation (HKSTP) congratulates BioMap, a Park company, on its strategic partnership with the Hong Kong Investment ...

The Biomedical Advanced Research and Development Authority (BARDA)[1] held its first in-person BARDA Industry Day (BID) since the beginning of the COVID-19 pandemic in Washington, D.C., on November 13 ...

Biomap (Beijing) Intelligent Technology Co Ltd. has entered into a strategic collaboration with Sanofi SA to co-develop cutting-edge artificial intelligence (AI) modules for biotherapeutic drug ...

Sanofi has assembled a stable of partnerships to carry out its goal of using artificial intelligence to bolster drug discovery, but those pacts mainly cover small molecule drugs. The pharmaceutical ...

Biomap expects to double its revenue this year, co-founder and CEO Wei Liu says Biomap, a biotechnology start-up co-established by Baidu founder Robin Li Yanhong and backed by the Hong Kong government ...